Patents by Inventor Daria Dmitrievna ELISEEVA

Daria Dmitrievna ELISEEVA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment method for relapsing-remitting multiple sclerosis
    Patent number: 9192628
    Abstract: Disclosed is a method for treating relapsing-remitting multiple sclerosis in a patient by administering to the patient autologous, ex vivo-expanded CD4+CD25+Foxp3+CD127low T reg cells when the patient is in remission. Also disclosed is a method of inhibiting the activity of autoimmune, autologous cytotoxic T and B cells in a patient suffering from relapsing-remitting multiple sclerosis, comprising administering a therapeutically effective amount of autologous CD4+CD25+Foxp3+CD127low T reg cells to the patient.
    Type: Grant
    Filed: February 21, 2014
    Date of Patent: November 24, 2015
    Assignee: REGENEX LLC
    Inventors: Svetlana Nunevna Bykovskaia, Daria Dmitrievna Eliseeva, Igor Alekseevich Zavalishin
  • TREATMENT METHOD FOR RELAPSING-REMITTING MULTIPLE SCLEROSIS
    Publication number: 20140170176
    Abstract: Disclosed is a method for treating relapsing-remitting multiple sclerosis in a patient by administering to the patient autologous, ex vivo-expanded CD4+CD25+Foxp3+CD127low T reg cells when the patient is in remission. Also disclosed is a method of inhibiting the activity of autoimmune, autologous cytotoxic T and B cells in a patient suffering from relapsing-remitting multiple sclerosis, comprising administering a therapeutically effective amount of autologous CD4+CD25+Foxp3+CD127low T reg cells to the patient.
    Type: Application
    Filed: February 21, 2014
    Publication date: June 19, 2014
    Applicant: REGENEX LLC
    Inventors: Svetlana Nunevna BYKOVSKAIA, Daria Dmitrievna ELISEEVA, Igor Alekseevich ZAVALISHIN
  • Treatment method for relapsing-remitting multiple sclerosis
    Patent number: 8697060
    Abstract: Disclosed is a method for treating relapsing-remitting multiple sclerosis in a patient by administering to the patient autologous, ex vivo-expanded CD4+CD25+Foxp3+CD127low T reg cells when the patient is in remission. Also disclosed is a method of inhibiting the activity of autoimmune, autologous cytotoxic T and B cells in a patient suffering from relapsing-remitting multiple sclerosis, comprising administering a therapeutically effective amount of autologous CD4+CD25+Foxp3+CD127low T reg cells to the patient.
    Type: Grant
    Filed: February 15, 2013
    Date of Patent: April 15, 2014
    Assignee: Regenex LLC
    Inventors: Svetlana Nunevna Bykovskaia, Daria Dmitrievna Eliseeva, Igor Alekseevich Zavalishin
  • TREATMENT METHOD FOR RELAPSING-REMITTING MULTIPLE SCLEROSIS
    Publication number: 20140004133
    Abstract: Disclosed is a method for treating relapsing-remitting multiple sclerosis in a patient by administering to the patient autologous, ex vivo-expanded CD4+CD25+Foxp3+CD127lowT reg cells when the patient is in remission. Also disclosed is a method of inhibiting the activity of autoimmune, autologous cytotoxic T and B cells in a patient suffering from relapsing-remitting multiple sclerosis, comprising administering a therapeutically effective amount of autologous CD4+CD25?Foxp3+CD127lowT reg cells to the patient.
    Type: Application
    Filed: February 15, 2013
    Publication date: January 2, 2014
    Applicant: Regenex LLC
    Inventors: Svetlana Nunevna BYKOVSKAIA, Daria Dmitrievna ELISEEVA, Igor Alekseevich ZAVALISHIN